Biobanks Market Size, Share & Trends Analysis Report By Product & Services (LIMS, Biobanking Equipment), By Biospecimen Type (Organs, Stem Cells), By Biobank Type (Real, Virtual), By Service, By Application, By Region, And Segment Forecasts, 2026 - 2033
Description
Biobanks Market Summary
The global biobanks market size was estimated at USD 86.82 billion in 2025 and is anticipated to reach USD 160.54 billion by 2033, growing at a CAGR of 8.11% from 2026 to 2033. High investments in the R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, are some of the driving factors.
Global Biobanks Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biobanks market report based on product & service, biospecimen type, biobank type, application, and region:
The global biobanks market size was estimated at USD 86.82 billion in 2025 and is anticipated to reach USD 160.54 billion by 2033, growing at a CAGR of 8.11% from 2026 to 2033. High investments in the R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, are some of the driving factors.
Global Biobanks Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biobanks market report based on product & service, biospecimen type, biobank type, application, and region:
- Product & Services Outlook (Revenue, USD Million, 2021 - 2033)
- Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers & Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators & Centrifuges
- Alarms & Monitoring Systems
- Accessories & Other Equipment
- Biobanking Consumables
- Laboratory Information Management Systems
- Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services
- Biospecimen Type Outlook (Revenue, USD Million, 2021 - 2033)
- Human Tissues
- Human Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
- Biobank Type Outlook (Revenue, USD Million, 2021 - 2033)
- Physical/Real Biobanks
- Tissue Biobanks
- Population-Based Biobanks
- Genetic (DNA/RNA)
- Disease-Based Biobanks
- Virtual Biobanks
- Application Type Outlook (Revenue, USD Million, 2021 - 2033)
- Therapeutics
- Drug Discovery & Clinical Research
- Clinical Diagnostics
- Other Applications
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Service
- 1.2.2. Service Provider
- 1.2.3. Application
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Research
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Expansion of direct-to-consumer health platforms
- 3.2.1.2. Rising consumer demand for individualized health solutions
- 3.2.1.3. Growing awareness of chronic disease prevention and wellness
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Data privacy and security concerns
- 3.2.2.2. Limited clinical evidence supporting long-term outcomes
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.4. AI Integration in Personalized Testing and Supplements Market
- 3.5. Consumer Behavior Analysis
- Chapter 4. Personalized Testing & Supplements Market: Service Business Analysis
- 4.1. Service Segment Dashboard
- 4.2. Global Personalized Testing & Supplements Market Service Movement Analysis
- 4.3. Global Personalized Testing & Supplements Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
- 4.4. Personalized Testing
- 4.4.1. Personalized Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Blood Tests
- 4.4.2.1. Global Blood Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. DNA Tests
- 4.4.3.1. Global DNA Tests Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Wearable Device & App-based Tests
- 4.4.4.1. Global Wearable Device & App-based Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.5. Others
- 4.4.5.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Personalized Recommendations
- 4.5.1. Personalized Recommendations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Fixed
- 4.5.2.1. Global Fixed Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.3. Repeat
- 4.5.3.1. Global Repeat Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.4. Continuous
- 4.5.4.1. Global Continuous Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Personalized Supplements
- 4.6.1. Personalized Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.2. Proteins & Amino Acid
- 4.6.2.1. Global Proteins & Amino Acid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.3. Vitamins
- 4.6.3.1. Global Vitamins Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.4. Minerals
- 4.6.4.1. Global Minerals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.5. Probiotics
- 4.6.5.1. Global Probiotics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.6. Herbal/Botanic
- 4.6.6.1. Global Herbal/Botanic Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6.7. Others
- 4.6.7.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Personalized Testing & Supplements Market: Service Provider Business Analysis
- 5.1. Service Provider Segment Dashboard
- 5.2. Global Personalized Testing & Supplements Market Service Provider Movement Analysis
- 5.3. Global Personalized Testing & Supplements Market Size & Trend Analysis, by Service Provider, 2021 to 2033 (USD Million)
- 5.4. Personalized Testing & Supplement Companies (DTC)
- 5.4.1. Global Personalized Testing & Supplement Companies (DTC) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Dieticians & Nutritionists
- 5.5.1. Global Dieticians & Nutritionists Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Others
- 5.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Personalized Testing & Supplements Market: Application Business Analysis
- 6.1. Application Segment Dashboard
- 6.2. Global Personalized Testing & Supplements Market Application Movement Analysis
- 6.3. Global Personalized Testing & Supplements Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 6.4. General Health & Wellness
- 6.4.1. Global General Health & Wellness Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Deficiency Management
- 6.5.1. Global Deficiency Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Others
- 6.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Personalized Testing & Supplements Market: Regional Estimates & Trend Analysis by Service, Service Provider, & Application
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 7.4. North America
- 7.4.1. North America Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. U.S.
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. U.S. Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Canada
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Canada Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. Mexico
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. Mexico Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Europe
- 7.5.1. Europe Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. UK
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. UK Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Germany
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Germany Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. France
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. France Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Italy
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Italy Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Spain
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Spain Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Denmark
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Denmark Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.8. Sweden
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Competitive Scenario
- 7.5.8.3. Regulatory Framework
- 7.5.8.4. Sweden Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.9. Norway
- 7.5.9.1. Key Country Dynamics
- 7.5.9.2. Competitive Scenario
- 7.5.9.3. Regulatory Framework
- 7.5.9.4. Norway Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Japan Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. China Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. India Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.5. Australia
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Australia Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.6. Thailand
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Thailand Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.7. South Korea
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. South Korea Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Brazil Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Argentina Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8. MEA
- 7.8.1. MEA Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. South Africa Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Saudi Arabia Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory Framework
- 7.8.4.4. UAE Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Competitive Scenario
- 7.8.5.3. Regulatory Framework
- 7.8.5.4. Kuwait Personalized Testing & Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Participant Categorization
- 8.2. Company Market Position Analysis, 2025
- 8.3. Participant’s Overview
- 8.3.1. Viome
- 8.3.1.1. Overview
- 8.3.1.2. Financial Performance
- 8.3.1.3. Product Benchmarking
- 8.3.1.4. Strategic Initiatives
- 8.3.2. Rootine
- 8.3.2.1. Overview
- 8.3.2.2. Financial Performance
- 8.3.2.3. Product Benchmarking
- 8.3.2.4. Strategic Initiatives
- 8.3.3. Bioniq
- 8.3.3.1. Overview
- 8.3.3.2. Financial Performance
- 8.3.3.3. Product Benchmarking
- 8.3.3.4. Strategic Initiatives
- 8.3.4. LifeNome
- 8.3.4.1. Overview
- 8.3.4.2. Financial Performance
- 8.3.4.3. Product Benchmarking
- 8.3.4.4. Strategic Initiatives
- 8.3.5. Vitl
- 8.3.5.1. Overview
- 8.3.5.2. Financial Performance
- 8.3.5.3. Product Benchmarking
- 8.3.5.4. Strategic Initiatives
- 8.3.6. Nutrigenomix Inc.
- 8.3.6.1. Overview
- 8.3.6.2. Financial Performance
- 8.3.6.3. Product Benchmarking
- 8.3.6.4. Strategic Initiatives
- 8.3.7. CircleDNA
- 8.3.7.1. Overview
- 8.3.7.2. Financial Performance
- 8.3.7.3. Product Benchmarking
- 8.3.7.4. Strategic Initiatives
- 8.3.8. GenoPalate
- 8.3.8.1. Overview
- 8.3.8.2. Financial Performance
- 8.3.8.3. Product Benchmarking
- 8.3.8.4. Strategic Initiatives
- 8.3.9. Sova Health
- 8.3.9.1. Overview
- 8.3.9.2. Financial Performance
- 8.3.9.3. Product Benchmarking
- 8.3.9.4. Strategic Initiatives
- 8.3.10. Myoform
- 8.3.10.1. Overview
- 8.3.10.2. Financial Performance
- 8.3.10.3. Product Benchmarking
- 8.3.10.4. Strategic Initiatives
- 8.3.11. VitaminLab
- 8.3.11.1. Overview
- 8.3.11.2. Financial Performance
- 8.3.11.3. Product Benchmarking
- 8.3.11.4. Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
